18F]ML10
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 18F]ML10, covering 2013-07-01 to 2013-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL) [Phase 1]